Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 14,493 shares at $20.13 ($291K) on 2024-02-28, disclosed to the SEC on 2024-02-29.
Scheduled sale ($291k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 745 | $15K | 5.1% |
| 2 | $20.13 | 5,849 | $118K | 40.4% |
| 3 | $20.13 | 5,849 | $118K | 40.4% |
| 4 | $20.00 | 2,050 | $41K | 14.1% |
| Total | $20.10 avg | 14,493 | $291K | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |